Cannabis

Science Says This Creates The Same Rush As Marijuana

Published

1 year ago

November 13, 2023

admin

Slowly, research is being done to better understand cannabis. Currently, it is been discovered it is helpful for stress, inflammation, PTSD, and more. Understanding the underlying way it works is critical to unlock more benefits. Now, science says this creates teh rush as marijuana, Yes, it is the same chemical and physiological avalanche is the human orgasm.

The brain is the largest sex organ in the body. Taking a closer look inside the brain is exactly what curious researchers are doing. While much scientific investigation into this question has examined the activity levels in specific areas of the brain, others seek to measure changes in chemical composition.

Researchers from Germany decided to examine the levels of certain endocannabinoids in blood plasma before and after subjects masturbated to orgasm. Endocannabinoids are chemical compounds which interact with receptors in cells altering neurotransmitter release in the brain. The concentrations of several chemicals were measured in the blood plasma of human subjects before and after they masturbated to orgasm.

Related: What Is Marijuana Use Doing To Your Penis?

Brain scans using functional MRI’s (FMRI) have shown during masturbation many areas of the brain are engaged. The hypothalamus becomes more active and amps up production of a powerful hormone called oxytocin acts as a neurotransmitter. The chemical has also been implicated in maternal-infant bonding, empathy and generosity. The thalamus and the substantia nigra, an area densely populated with dopamine-producing neurons, are also highly engaged. Previous research out of Rutgers University has suggested the orgasm creates a type of altered state of reality.

2-AG is the most abundant endocannabinoid in the human body. It is also present in mother’s milk and is believed to regulate appetite, our immune system and to manage pain. The German researchers found masturbating to orgasm significantly increased the amount of the endocannabinoid 2-AG in blood plasma.

Our data indicate the endocannabinoid 2-AG is involved in the human sexual response cycle and we hypothesize 2-AG release plays a role in the rewarding consequences of sexual arousal and orgasm.

This sort of finding is of great interest to the pharmaceutical industry, it may open an opportunity to explore the ways a prescribed medicine could affect cannabinoid levels. Making people’s sexual lives richer is big business. The erectile dysfunction medicine market was worth over $3 billion in 2020 and is expected to grow to $7.1 billion by 2030.

The chemistry of cannabis may have a role to play in yet another area of our personal health. There is much work still to be done. Follow up studies are bound to follow this line of questioning to explore how cannabis-based medicine may help improve peoples’ sex lives. So, for the good of our collective health, if a reputable team of scientists asks you to masturbate for money in a lab setting, do it for science.

Source link

Cannabis

White House Finally Comments On Marijuana Industry

Published

5 hours ago

April 1, 2025

admin

Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.

Source link

Cannabis

This State’s Cannabis Revenue Keeps Pouring In

Published

1 day ago

March 31, 2025

admin

States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.

The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.

RELATED: Mike Johnson And Marijuana

“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”

Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.

States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.

In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.

Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.

The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.

This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.

Source link

Cannabis

Mixed Messages From The Feds About Cannabis

Published

4 days ago

March 28, 2025

admin

The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.

The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.

The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.

The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.

Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.

In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.

This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.

Source link